Special Report: Reimagining QbD

In this complimentary 18-page report, leading industry and regulatory experts explore what QbD will look like in its adolescence, and how manufacturers can "reimagine" Quality by Design as a fundamental strategy involving risk, life-cycle cost, competitiveness . . . and survival. The document-which also includes links to key web resources illustrating current FDA thinking and industry practices regarding QbD-is essential for anyone wanting to know where QbD stands today, and where it's headed. Read Now.